Elite Pharmaceuticals Inc (ELTP)

[Pharma Sleuth]

The AR is the big number. Look at what it was 6 months ago and then last Q and then this Q. 3 to 10 to 16. It's as big as the current revenue. That is crazy

You don't need an MBA to see what is happening.

The debt to asset one is still what blows my mind. A lot of companies would take on more debt for products. It's kind of the American way these days but from a valuation perspective considering what is already in the pipeline and what it costs them to take a product from a tube to a trial, it's a license to print money.

And again still not including the the CNS drugs coming this year.

The other point about the debt is they have no overhang. Nothing sucking money away to interest charges with a currently very high prime rate.

That allows them to be extremely cost competitive. It can't be overstated